Reference health

Excess Commitment in R&D

https://doi.org/10.2139/ssrn.4558321
CiteStamped reference-health badge
55/55 checkable references clean · checked 2026-08-20

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

18 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 55 checked references that resolve
resolves10.1162/0033553041502144
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
resolves10.1016/j.jfineco.2021.05.055
IPO peer effects
resolves10.1111/1475-679X.12396
Do Mandatory Disclosure Requirements for Private Firms Increase the Propensity of Going Public?
resolves10.2307/2951599
A Model of Growth Through Creative Destruction
resolves10.1093/restud/rdv037
The Sunk-Cost Fallacy in Penny Auctions
resolves10.1093/restud/rdy034
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
resolves10.1016/j.jfineco.2021.06.007
The micro and macro of managerial beliefs
resolves10.1257/aer.103.3.208
A Trapped-Factors Model of Innovation
resolves10.1111/jofi.13321
Mergers, Product Prices, and Innovation: Evidence from the Pharmaceutical Industry
resolves10.1016/bs.hesind.2021.11.013
Innovation: market failures and public policies
resolves10.1257/aer.20131176
Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials
resolves10.1016/S0167-2681(99)00026-8
The econometrics and behavioral economics of escalation of commitment: a re-examination of Staw and Hoang’s NBA data
resolves10.1016/j.jfineco.2004.09.004
Managerial incentives and risk-taking☆
resolves10.1111/1475-679X.00064
Estimating the Value of Employee Stock Option Portfolios and Their Sensitivities to Price and Volatility
resolves10.1016/S0167-6296(02)00126-1
The price of innovation: new estimates of drug development costs
resolves10.1016/j.jhealeco.2016.01.012
Innovation in the pharmaceutical industry: New estimates of R&D costs
resolves10.1515/9781400830176
Investment under Uncertainty
resolves10.1093/rfs/hhn117
A Multiplicative Model of Optimal CEO Incentives in Market Equilibrium
resolves10.1086/260866
Agency Problems and the Theory of the Firm
resolves10.1086/261826
Optimal Incentive Contracts in the Presence of Career Concerns: Theory and Evidence
resolves10.1111/jofi.13430
In Too Deep: The Effect of Sunk Costs on Corporate Investment
resolves10.1093/acrefore/9780190625979.013.457
Behavioral Corporate Finance: The Life Cycle of a CEO Career
resolves10.1093/rfs/hhq009
New Evidence on Measuring Financial Constraints: Moving Beyond the KZ Index
resolves10.1016/S0169-7218(10)01014-2
The Financing of R&D and Innovation
resolves10.1287/mnsc.2019.3530
Rushed Innovation: Evidence from Drug Licensing
resolves10.1016/j.jfineco.2005.04.004
The outsourcing of R&D through acquisitions in the pharmaceutical industry
resolves10.1287/mnsc.2016.2651
Sunk Cost Fallacy in Driving the World’s Costliest Cars
resolves10.1017/S002210902400084X
Information Disclosure and Peer Innovation: Evidence from Mandatory Reporting of Clinical Trials
resolves10.2307/1914185
Prospect Theory: An Analysis of Decision under Risk
resolves10.1162/003355397555163
Do Investment-Cash Flow Sensitivities Provide Useful Measures of Financing Constraints?
resolves10.1016/j.jeconom.2005.02.011
Generalized reduced rank tests using the singular value decomposition
resolves10.1093/rfs/hhab024
Missing Novelty in Drug Development
resolves10.1287/mnsc.2021.4243
Find and Replace: R&D Investment Following the Erosion of Existing Products
resolves10.1136/jim-2015-000010
Investigational New Drug Applications: A 1-Year Pilot Study on Rates and Reasons for Clinical Hold
resolves10.1257/aer.100.1.214
Contractibility and the Design of Research Agreements
resolves10.1016/S0304-405X(02)00256-8
Do equity financing cycles matter? evidence from biotechnology alliances
resolves10.1016/j.jfineco.2022.12.004
Common ownership and innovation efficiency
resolves10.1146/annurev-financial-031721-081537
Financing Biomedical Innovation
resolves10.1017/S0022109022001053
The Real Effects of Equity Markets on Innovation
resolves10.1111/j.1467-6451.2009.00398.x
THE ROLE OF SUNK COSTS IN THE DECISION TO INVEST IN R&amp;D<sup>*</sup>
resolves10.1111/j.1540-6261.2011.01688.x
Motivating Innovation
resolves10.1111/j.1465-7295.2008.00184.x
DO SUNK COSTS MATTER?
resolves10.1146/annurev-economics-080315-015136
Patents and Innovation in Economic History
resolves10.2307/2938192
Long-term, Short-term and Renegotiation: On the Value of Commitment in Contracting
resolves10.1086/519811
Financial Contracting in Biotech Strategic Alliances
resolves10.1177/1740774515625964
Key cost drivers of pharmaceutical clinical trials in the United States
resolves10.1001/jamanetworkopen.2022.50996
Analysis of Rates of Completion, Delays, and Participant Recruitment in Randomized Clinical Trials in Surgery
resolves10.1016/0030-5073(76)90005-2
Knee-deep in the big muddy: a study of escalating commitment to a chosen course of action
resolves10.2307/2393794
Sunk Costs in the NBA: Why Draft Order Affects Playing Time and Survival in Professional Basketball
resolves10.1037/0021-9010.82.1.130
Escalation at the credit window: A longitudinal study of bank executives' recognition and write-off of problem loans.
resolves10.1198/073500102288618658
A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments
resolves10.1017/S0022109021000284
Competition and R&amp;D Financing: Evidence From the Biopharmaceutical Industry
resolves10.1093/rfs/hhj012
Financial Constraints Risk
resolves10.1093/biostatistics/kxx069
Estimation of clinical trial success rates and related parameters
resolves10.1001/jama.2020.1166
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
The 18 references without a DOI — listed, not checked
no DOI — not checkedResearch and development in the pharmaceutical industry
no DOI — not checkedInternal deadlines, drug approvals, and safety problems
no DOI — not checked2021. Killer acquisitions
no DOI — not checkedref23
no DOI — not checkedOrganizational scope and investment: Evidence from the drug development strategies and performance of biopharmaceutical firms
no DOI — not checkedCost of capital for pharmaceutical, biotechnology, and medical device firms
no DOI — not checkedManagerial incentive schemes: A dynamic perspective
no DOI — not checkedLearning by investing: Entrepreneurial spillovers from venture capital
no DOI — not checkedref46
no DOI — not checkedFinancial intermediation and the funding of biomedical innovation: A review
no DOI — not checkedA quantitative analysis of distortions in managerial forecasts
no DOI — not checkedBehavioral corporate finance
no DOI — not checkedref55
no DOI — not checkedref57
no DOI — not checkedref58
no DOI — not checkedPfizer to showcase diverse and growing oncology portfolio at the
no DOI — not checkedIrreversibility, uncertainty, and investment
no DOI — not checkedref72
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-20 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4558321"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4558321/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4558321/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4558321)